E.P.T.Q. S300 (1×1ml)

Avoid alcohol for 24h before and 48h after the procedure. Alcohol acts as a vasodilator, which can increase blood flow to the treatment site, exacerbating post-injection swelling and increasing the risk of visible bruising.

Treatment is strictly contraindicated. No clinical safety data exists for cross-linked HA fillers during pregnancy. Practitioners must monitor for signs of vascular occlusion in all patients and defer elective procedures for those who are pregnant to ensure maternal health.

Dosage is individualized based on the area of treatment and the desired volume. For nasolabial folds, 0.5 ml to 1.0 ml per side is standard. Practitioners should evaluate if 0.5 ml of filler is sufficient for minor asymmetry correction before utilizing the full syringe. For structural lip work, it provides more projection than Restylane Kysse while maintaining high elasticity.

Common reactions include temporary redness, swelling, and localized purple bruising at the injection site. These effects typically resolve within 3 to 7 days. Patients should follow our expert aftercare guide to ensure a smooth recovery. Clinicians must always have Liporase (Hyaluronidase) available in the clinic to manage any unexpected tissue irregularities.

The gel acts as a mechanical support, physically displacing the mid-to-deep dermis to smooth wrinkles and add volume. Its uniform particle size ensures even distribution, which is critical for avoiding filler lumps and nodules. Unlike lighter skin boosters, S300 provides structural longevity while the HA cross-linking allows it to move naturally with facial expressions.

The formulation contains 24 mg/ml of monophasic cross-linked Hyaluronic Acid and 0.3% Lidocaine hydrochloride. This concentration is comparable to the premium gels in our Juvederm brand overview, offering excellent durability.